108 related articles for article (PubMed ID: 28427696)
1. Genetic burden of MS risk variants distinguish patients from healthy individuals but are not associated with disease activity.
Søndergaard HB; Petersen ER; Magyari M; Sellebjerg F; Oturai AB
Mult Scler Relat Disord; 2017 Apr; 13():25-27. PubMed ID: 28427696
[TBL] [Abstract][Full Text] [Related]
2. The burden of multiple sclerosis variants in continental Italians and Sardinians.
Barizzone N; Zara I; Sorosina M; Lupoli S; Porcu E; Pitzalis M; Zoledziewska M; Esposito F; Leone M; Mulas A; Cocco E; Ferrigno P; Guerini FR; Brambilla P; Farina G; Murru R; Deidda F; Sanna S; Loi A; Barlassina C; Vecchio D; Zauli A; Clarelli F; Braga D; Poddie F; Cantello R; Martinelli V; Comi G; Frau J; Lorefice L; Pugliatti M; Rosati G; ; Melis M; Marrosu MG; Cusi D; Cucca F; Martinelli Boneschi F; Sanna S; D'Alfonso S
Mult Scler; 2015 Oct; 21(11):1385-95. PubMed ID: 26438306
[TBL] [Abstract][Full Text] [Related]
3. Single-nucleotide polymorphisms in HLA- and non-HLA genes associated with the development of antibodies to interferon-β therapy in multiple sclerosis patients.
Weber F; Cepok S; Wolf C; Berthele A; Uhr M; Bettecken T; Buck D; Hartung HP; Holsboer F; Müller-Myhsok B; Hemmer B
Pharmacogenomics J; 2012 Jun; 12(3):238-45. PubMed ID: 21502966
[TBL] [Abstract][Full Text] [Related]
4. Burden of risk variants correlates with phenotype of multiple sclerosis.
Hilven K; Patsopoulos NA; Dubois B; Goris A
Mult Scler; 2015 Nov; 21(13):1670-80. PubMed ID: 25948629
[TBL] [Abstract][Full Text] [Related]
5. Integration of genetic risk factors into a clinical algorithm for multiple sclerosis susceptibility: a weighted genetic risk score.
De Jager PL; Chibnik LB; Cui J; Reischl J; Lehr S; Simon KC; Aubin C; Bauer D; Heubach JF; Sandbrink R; Tyblova M; Lelkova P; ; ; ; ; Havrdova E; Pohl C; Horakova D; Ascherio A; Hafler DA; Karlson EW
Lancet Neurol; 2009 Dec; 8(12):1111-9. PubMed ID: 19879194
[TBL] [Abstract][Full Text] [Related]
6. Genetic risk factors for pediatric-onset multiple sclerosis.
Gianfrancesco MA; Stridh P; Shao X; Rhead B; Graves JS; Chitnis T; Waldman A; Lotze T; Schreiner T; Belman A; Greenberg B; Weinstock-Guttman B; Aaen G; Tillema JM; Hart J; Caillier S; Ness J; Harris Y; Rubin J; Candee M; Krupp L; Gorman M; Benson L; Rodriguez M; Mar S; Kahn I; Rose J; Roalstad S; Casper TC; Shen L; Quach H; Quach D; Hillert J; Hedstrom A; Olsson T; Kockum I; Alfredsson L; Schaefer C; Barcellos LF; Waubant E;
Mult Scler; 2018 Dec; 24(14):1825-1834. PubMed ID: 28980494
[TBL] [Abstract][Full Text] [Related]
7. CD46 in a Spanish cohort of multiple sclerosis patients: genetics, mRNA expression and response to interferon-beta treatment.
Alvarez-Lafuente R; Blanco-Kelly F; Garcia-Montojo M; Martínez A; De Las Heras V; Dominguez-Mozo MI; Bartolome M; Garcia-Martinez A; De la Concha EG; Urcelay E; Arroyo R
Mult Scler; 2011 May; 17(5):513-20. PubMed ID: 21177319
[TBL] [Abstract][Full Text] [Related]
8. Genome-wide pharmacogenomic analysis of the response to interferon beta therapy in multiple sclerosis.
Byun E; Caillier SJ; Montalban X; Villoslada P; Fernández O; Brassat D; Comabella M; Wang J; Barcellos LF; Baranzini SE; Oksenberg JR
Arch Neurol; 2008 Mar; 65(3):337-44. PubMed ID: 18195134
[TBL] [Abstract][Full Text] [Related]
9. Risk genes associated with pediatric-onset MS but not with monophasic acquired CNS demyelination.
van Pelt ED; Mescheriakova JY; Makhani N; Ketelslegers IA; Neuteboom RF; Kundu S; Broer L; Janssens C; Catsman-Berrevoets CE; van Duijn CM; Banwell B; Bar-Or A; Hintzen RQ
Neurology; 2013 Dec; 81(23):1996-2001. PubMed ID: 24198294
[TBL] [Abstract][Full Text] [Related]
10. Killer cell immunoglobulin-like receptor genes in Spanish multiple sclerosis patients.
García-León JA; Pinto-Medel MJ; García-Trujillo L; López-Gómez C; Oliver-Martos B; Prat-Arrojo I; Marín-Bañasco C; Suardíaz-García M; Maldonado-Sanchez R; Fernández-Fernández O; Leyva-Fernández L
Mol Immunol; 2011 Sep; 48(15-16):1896-902. PubMed ID: 21665278
[TBL] [Abstract][Full Text] [Related]
11. Genetic contribution to multiple sclerosis risk among Ashkenazi Jews.
Khankhanian P; Matsushita T; Madireddy L; Lizée A; Din L; Moré JM; Gourraud PA; Hauser SL; Baranzini SE; Oksenberg JR
BMC Med Genet; 2015 Jul; 16():55. PubMed ID: 26212423
[TBL] [Abstract][Full Text] [Related]
12. Rare MEFV variants are not associated with risk to develop multiple sclerosis and severity of disease.
Pauwels I; Cosemans L; Boonen S; Dubois B; Goris A
Mult Scler; 2013 Aug; 19(9):1132-6. PubMed ID: 23325590
[TBL] [Abstract][Full Text] [Related]
13. Evidence for the genetic role of human leukocyte antigens in low frequency DRB1*1501 multiple sclerosis patients in Israel.
Karni A; Kohn Y; Safirman C; Abramsky O; Barcellos L; Oksenberg JR; Kahana E; Karussis D; Chapman J; Brautbar C
Mult Scler; 1999 Dec; 5(6):410-5. PubMed ID: 10618697
[TBL] [Abstract][Full Text] [Related]
14. IFNAR1 and IFNAR2 polymorphisms confer susceptibility to multiple sclerosis but not to interferon-beta treatment response.
Leyva L; Fernández O; Fedetz M; Blanco E; Fernández VE; Oliver B; León A; Pinto-Medel MJ; Mayorga C; Guerrero M; Luque G; Alcina A; Matesanz F
J Neuroimmunol; 2005 Jun; 163(1-2):165-71. PubMed ID: 15885318
[TBL] [Abstract][Full Text] [Related]
15. Multiple sclerosis susceptibility loci do not alter clinical and MRI outcomes in clinically isolated syndrome.
Kalincik T; Guttmann CR; Krasensky J; Vaneckova M; Lelkova P; Tyblova M; Seidl Z; De Jager PL; Havrdova E; Horakova D
Genes Immun; 2013 Jun; 14(4):244-8. PubMed ID: 23575354
[TBL] [Abstract][Full Text] [Related]
16. [Multiple sclerosis with early onset: pathogenesis, clinical characteristics, possibilities in the treatment of its pathogenesis].
Maslova OI; Bykova OV; Guseva MR; Sidorenko EI; Boĭko SIu; Sudomoina MV; Studenikin VM; Shchelkovskiĭ VI; Favorova OO
Zh Nevrol Psikhiatr Im S S Korsakova; 2002; Suppl():46-51. PubMed ID: 12418392
[TBL] [Abstract][Full Text] [Related]
17. HLA class II and response to interferon-beta in multiple sclerosis.
Fernández O; Fernández V; Mayorga C; Guerrero M; León A; Tamayo JA; Alonso A; Romero F; Leyva L; Alonso A; Luque G; de Ramón E
Acta Neurol Scand; 2005 Dec; 112(6):391-4. PubMed ID: 16281922
[TBL] [Abstract][Full Text] [Related]
18. Single-nucleotide polymorphisms in response to interferon-beta therapy in multiple sclerosis.
Vandenbroeck K; Comabella M
J Interferon Cytokine Res; 2010 Oct; 30(10):727-32. PubMed ID: 20836710
[TBL] [Abstract][Full Text] [Related]
19. The association of HLA-DRB1 and HLA-DQB1 alleles with genetic susceptibility to multiple sclerosis in the Slovak population.
Michalik J; Čierny D; Kantorová E; Kantárová D; Juraj J; Párnická Z; Kurča E; Dobrota D; Lehotský J
Neurol Res; 2015; 37(12):1060-7. PubMed ID: 26744784
[TBL] [Abstract][Full Text] [Related]
20. Multiple sclerosis in families: risk factors beyond known genetic polymorphisms.
Akkad DA; Lee DH; Bruch K; Haghikia A; Epplen JT; Hoffjan S; Linker RA
Neurogenetics; 2016 Apr; 17(2):131-5. PubMed ID: 26865406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
